General Information
Version
4
Revision date
2026-07-14
Product name
EMULSION APRAPOLE DPN855
1.2.1 Relevant identified uses
Professional applications
Manufacturer Name
PPG AP Resinas, SA de CV
Icons in SDS
Company Information
company name
PPG AP Resinas, SA de CV
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H370
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Ingredient(s) with unknown acute toxicity
46% (oral), 47.5% (dermal), 50.4% (inhalation)
Signal word
Danger
Hazard statements
Causes skin irritation. Causes serious eye irritation. Causes damage to organs. (respiratory tract)
Prevention
Wear protective gloves. Wear eye or face protection. Do not breathe vapor. Do not eat, drink or smoke when using this product. Wash thoroughly after handling.
Response
IF exposed or concerned Call a POISON CENTER or doctor. IF ON SKIN Wash with plenty of water. If skin irritation occurs: Get medical advice or attention. Take off contaminated clothing and wash it before reuse. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice or attention.
Storage
Store locked up.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
Contains isothiazolinones. May cause allergic reaction. Do not taste or swallow. This product either contains formaldehyde or is capable of releasing formaldehyde above 0.5 ppm under certain conditions. Formaldehyde is a known cancer hazard, a skin sensitizer and a respiratory sensitizer. Wash thoroughly after handling. Emits toxic fumes when heated.
2.3 Other hazards
Causes digestive tract burns.
2.1 Classification of the substance or mixture
substance or mixture EYE IRRITATION - Category 2A SPECIFIC TARGET ORGAN TOXICITY (SINGLE EXPOSURE) - Category 1 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 46% (oral), 47.5% (dermal), 50.4% (inhalation)